Samsung has formed a strategic partnership with Galeon, a pioneer in decentralized science (DeSci) and healthcare artificial intelligence (AI). Their aim is to detect congenital health conditions with AI-powered ultrasound.
The hope is to deliver real-world Web3 healthcare integration. The initiative connects Samsung’s new AI-powered ultrasound devices, designed to help detect congenital conditions, with Galeon’s Electronic Health Record (EHR), an in-production platform already live across 18 interconnected hospitals in Europe.
Benjamin Tarter, head of women’s health at Samsung France, said in a statement, “We are incredibly proud of this partnership and ready to disrupt the health market together.”
The partnership will debut in women’s health with a device-to-EHR integration that brings AI imaging data directly into established clinical workflows. By connecting Samsung’s hardware ecosystem with Galeon’s software and data infrastructure, clinicians can capture and interpret structured imaging data in real-time while maintaining a privacy-first focus. Galeon’s architecture is built on decentralized principles to keep patient privacy non-negotiable and to reduce administrative burden, returning valuable time to caregivers, and supporting better, faster decisions at the point of care.
Galeon’s Blockchain Swarm Learning (BSL®) enables hospitals to train medical AI on decentralized, anonymized datasets without centralizing raw patient information. Each institution retains full ownership and control of its data while still benefiting from transparent, high-quality model training.
This allows Galeon’s structured, standards-based records to become the fuel for safe, more accurate medical AI — moving healthcare from reactive treatment to proactive, preventative medicine on a national scale.
Loïc Brotons, CEO at Galeon, said in a statement, “Samsung’s device leadership meets our in-production EHR and decentralized AI stack to provide what the industry has been missing. Starting in women’s health, we are connecting AI imaging, real-time hospital workflows, and community-governed research to accelerate discoveries while protecting
privacy.”
The collaboration also establishes a live, decentralized research loop through Galeon’s Atlantis platform and the $GALEON token. A community of over 100,000 supporters can opt to share anonymized data with the Galeon DAO and vote to fund medical studies. This aligns research priorities with real-world patient needs and makes medical funding more community-driven and transparent.
Atlantis, launched to simplify participation and governance, works hand-in-hand with Galeon’s EHR footprint, which serves over 10,000 caregivers monthly and supports thousands of monthly users on the investment platform with approximately 100 daily active participants.